News
PADN Presented at ESC2017
Original innovative ideas and techniques amaze ESC audiences
CBS2017
丨Aug 28,2017
Barcelona, Spain---European Society of Cardiology (ESC) , opened its annual congress to great fanfare at local time 8:30am on 28 August. Over 30,000 medical experts and practitioners are gathering together to Barcelona. The ESC is a world leading not-for-profit medical society in the discovery and dissemination of best practices in cardiovascular medicine. Until now, ESC unites 95,000 experts from 56 National Cardiac Societies, 46 cardiovascular ESC sub-specialty communities and 27 Affiliated Cardiac Societies around the world.
On the first day, ESC released guidelines in four clinical relevant domains: 2017 Focused update on Dual Antiplatelet Therapy (DAPT); Management of Acute Myocardial Infarction in patients presenting with ST-segment elevation; Diagnosis and Treatment of Peripheral Arterial Diseases and Management of Valvular Heart Disease.
With low cure rate, high mortality rate and high therapy costs, pulmonary hypertension(PAH) is still a global public health issue. Some patients cannot benefit from standard medication therapy, even using multi target therapy. It is urgent to find another way than pharmacological treatment to solve more valuable lives. Prof Shaoliang Chen proposed innovatively pulmonary artery denervation in 2013 and presented their successful results from pre-clinical study to clincial study on the 27th at ESC2017.
From 9am to 10am on 28 August, the third day of ESC congress, Prof Chen will present another anticipated topic "coronary intervention" in ESC symposium 26!
This time, all ESC attendees could get further information at the conference site about CBS2017 which will begin on 30 November in Nanjing, China. As a frontier of left main and coronary bifurcation lesions, we sincerely welcome global cardiologists and experts come to Nanjing to share your new ideas and techniques for a better world.
Upnext
NEWS丨CBSMD
CBSMD丨Jun 28,2020
Upnext
NEWS丨CBSMD
CBSMD丨May 14,2020